维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Hug V"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Use of growth-stimulatory hormones to improve the in vitro therapeutic index of doxorubicin for human breast tumors显示文摘	Johnston D Finders M	1986	Cancer Res1986，46，1：	1
2	Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count显示文摘	Hug V Keating M McCredie K	1983	Cancer1983，52，5：	1
3	Advantages and disadvantages of different nasal CPAP systems in newborns显示文摘	Buettiker V Hug MI Baenziger O	2004	Intens Care Med2004，30，5：	1
4	Chemotherapy and hormonal therapy in combination显示文摘	Hug V Thames H Clark J	1988	J Clin Oncol1988，6，1：	1
5	Predictive factors for the success ofnoninvasive mask ventilation in infants and children with acuterespiratory failure 显示文摘	Bemet V Hug MI Frey B	2005	Pediatr Crit Care Med2005，6，6：	1
6	Advantages and disadvantages of different nasal CPAP systems in newborns显示文摘	Buettiker V Hug MI Baenziger O	2004	Intens Care Med2004，30，5：	1
7	Somatostatin:a new thenlpeutic option for the treatment of chylothorax显示文摘	Buettiker V Hug MI Burger R	2001	lntensive Care Med2001，27，10：	1
8	Tamoxifen - citrate counteracts the antitumor effects of cytotoxic drugs in vitro显示文摘	Hortobagyi GN Drewinko B	1985	J Clin Oncol1985，3，12：	1
9	Oncoid growth and distribution controlled by sea-level fluctuations and climate (Late Oxfordian, Swiss Jura Mountains)显示文摘	Stéphanie Védrine André Strasser Wolfgang Hug	2007	Facies2007，，4：	1
10	Predictive factors for the success of noninvasive mask ventilation in infants and children with acute respiratory failure 显示文摘	Bernet V Hug MI Frey B	2005	Pediatr Crit Care Med2005，6，6：	1
11	Advantages and dis- advantages of different nasal CPAP systems in newborns显示文摘	Buettiker V Hug MI Baenziger O	2004	Intens Care Med2004，30，5：	1
12	Clinical course and response to treatment of patients with acute myelogenous leukemia presenting with a high leukocyte count 显示文摘	Hug V Keating M McCredie K	1983	Cancer1983，52，5：	1
13	Somatostatin: a new therapeutic option for the treatment of chylothorax显示文摘	Buettiker V Hug MI Burger R	2001	Intensive Care Med2001，27，：	1
14	lnternet- based GPS VRS RTK positioning with a muhiple reference station network显示文摘	HUG R KHOO V H S GOH P C	2002	Journal of Global Positioning Systems2002，1，2：	1
15	Somatostatin:a new therapeutic option for the treatment of chylothorax显示文摘	BUETTIKER V HUG M I BURGER R	2001	Intensive Care Med2001，27，6：	1
16	Somatostatin :a new therapeutic option for the treatment of chylothorax 显示文摘	Buettiker V Hug MI Burger R	2001	Intensive Care Med2001，27，6：	1
17	Advantages and disadvantages of different nasal CPAP systems in newborns显示文摘	Buettiker V Hug MI Baenziger O	2004	Intens Care Med2004，30，5：	1
18	Quantitation of 1-beta- D-arahinofuranosylcytosine 5-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta D-arabinofuranosylcytosine therapy显示文摘	Plunkett W Hug V Keating MJ	1980	Cancer Res1980，40，3：	1
19	Advantages and disad- vantages of different nasal CPAP syatems in newborns 显示文摘	Buettiker V Hug MI Baenziger O	2004	Intens Careed2004，30，5：	1
20	Advantages and disadvantages of different nasal CPAP systems in newborns显示文摘	Buettiker V Hug MI Baenziger O	2004	Intensive Care Med2004，30，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示